{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T21:50:16Z","timestamp":1725745816847},"reference-count":16,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T00:00:00Z","timestamp":1237939200000},"content-version":"vor","delay-in-days":7023,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Toxicology"],"published-print":{"date-parts":[[1990,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Amperozide, a new putatively antipsychotic compound, has been evaluated for its effect on conditioned avoidance response and food\u2010reinforced lever\u2010pressing. Given alone, amperozide was almost equipotent to clozapine, but less potent than haloperidol in both test models. It was found that there was a statistically significant synergism, in these two models, between amperozide and classical neuroleptics. Since amperozide is inactive in behavioural tests reflecting striatal dopaminergic mechanisms, the synergistic effect could be of great therapeutic value in the treatment of psychotic disorders.<\/jats:p>","DOI":"10.1111\/j.1600-0773.1990.tb01601.x","type":"journal-article","created":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T18:36:02Z","timestamp":1238006162000},"page":"18-21","source":"Crossref","is-referenced-by-count":15,"title":["Amperozide and conditioned behaviour in rats: potentiation by classical neuroleptics and \u03b1\u2010methylparatyrosine"],"prefix":"10.1111","volume":"66","author":[{"given":"Patrik","family":"Egbe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rgen","family":"Engel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Christensson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,3,25]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(71)90172-5"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1973.tb10615.x"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1977.tb02059.x"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1982.tb01032.x"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01260898"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01244665"},{"key":"e_1_2_1_8_1","unstructured":"Christensson E. A.Bj\u00f6rk B.Gustafsson I.Magee V.Nerme&N.\u2010G.Olsson:FG5606 a new antiaggressive compound with effects on different stress\u2010induced disorders. IIIrd World Congress of Biological Psychiatry Stockholm Sweden June 28 \u2010\u2010 July 3 1981. (Abstract)."},{"issue":"542","key":"e_1_2_1_9_1","first-page":"281","article-title":"Amperozide, a novel psychotropic compound with specific effect on limbic brain areas (Abstract)","volume":"124","author":"Christensson E.","year":"1985","journal-title":"Acta Physiol. Scand."},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1990.tb01603.x"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1990.tb01600.x"},{"key":"e_1_2_1_12_1","first-page":"S17","article-title":"Amperozide \u2010\u2010 a new putative antipsychotic compound with selectivity to limbic brain functions","volume":"89","author":"Gustafsson B.","year":"1986","journal-title":"Psychopharmacology"},{"key":"e_1_2_1_13_1","first-page":"279","article-title":"Correlation in rats between the locomotor and avoidance suppressant potencies of eight phenothiazine tranquilizers","volume":"132","author":"Irwin S.","year":"1961","journal-title":"Arch. Int. Pharmacodyn."},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1990.tb01605.x"},{"issue":"542","key":"e_1_2_1_15_1","first-page":"221","article-title":"Chronic amperozide treatment regulates 5\u2010HT2 receptors labelled by 3H\u2010ketanserin","volume":"124","author":"Svartengren J.","year":"1985","journal-title":"Acta Physiol. Scand."},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1990.tb01599.x"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770040061011"}],"container-title":["Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0773.1990.tb01601.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0773.1990.tb01601.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T09:35:25Z","timestamp":1695720925000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0773.1990.tb01601.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,1]]},"references-count":16,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[1990,1]]}},"alternative-id":["10.1111\/j.1600-0773.1990.tb01601.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0773.1990.tb01601.x","archive":["Portico"],"relation":{},"ISSN":["0901-9928"],"issn-type":[{"value":"0901-9928","type":"print"}],"subject":[],"published":{"date-parts":[[1990,1]]}}}